Free Trial
NASDAQ:HSDT

Helius Medical Technologies (HSDT) Stock Price, News & Analysis

Helius Medical Technologies logo
$17.46 +1.23 (+7.54%)
As of 01:24 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Helius Medical Technologies Stock (NASDAQ:HSDT)

Advanced

Key Stats

Today's Range
$16.55
$17.68
50-Day Range
$5.55
$24.13
52-Week Range
$5.37
$1,200.00
Volume
892,922 shs
Average Volume
336,431 shs
Market Capitalization
$18.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Helius Medical Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

HSDT MarketRank™: 

Helius Medical Technologies scored higher than 33% of companies evaluated by MarketBeat, and ranked 751st out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Helius Medical Technologies is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Helius Medical Technologies is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Helius Medical Technologies has a P/B Ratio of 0.08. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Helius Medical Technologies' valuation and earnings.
  • Percentage of Shares Shorted

    1.34% of the outstanding shares of Helius Medical Technologies have been sold short.
  • Short Interest Ratio / Days to Cover

    Helius Medical Technologies has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Helius Medical Technologies has recently decreased by 5.23%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Helius Medical Technologies does not currently pay a dividend.

  • Dividend Growth

    Helius Medical Technologies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.34% of the outstanding shares of Helius Medical Technologies have been sold short.
  • Short Interest Ratio / Days to Cover

    Helius Medical Technologies has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Helius Medical Technologies has recently decreased by 5.23%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Helius Medical Technologies has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Helius Medical Technologies this week, compared to 1 article on an average week.
  • Search Interest

    10 people have searched for HSDT on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Helius Medical Technologies to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Helius Medical Technologies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.90% of the stock of Helius Medical Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 18.63% of the stock of Helius Medical Technologies is held by institutions.

  • Read more about Helius Medical Technologies' insider trading history.
Receive HSDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helius Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HSDT Stock News Headlines

Shots officially fired…
Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the rights to deliver direct-to-cell service nationwide — a move tech analyst Jeff Brown says could shape the backbone of the coming space economy and create fortunes on a scale not seen since the rise of NVIDIA.tc pixel
See More Headlines

HSDT Stock Analysis - Frequently Asked Questions

Helius Medical Technologies' stock was trading at $502.7250 at the start of the year. Since then, HSDT stock has decreased by 96.6% and is now trading at $17.1550.

Helius Medical Technologies, Inc. (NASDAQ:HSDT) released its quarterly earnings results on Thursday, August, 14th. The company reported ($79.73) earnings per share (EPS) for the quarter, topping the consensus estimate of ($128.50) by $48.77. The firm earned $0.04 million during the quarter, compared to analysts' expectations of $0.11 million. Helius Medical Technologies had a negative net margin of 7,215.25% and a negative trailing twelve-month return on equity of 699.93%.

Helius Medical Technologies shares reverse split before market open on Tuesday, July 1st 2025.The 1-50 reverse split was announced on Friday, June 27th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 30th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of HSDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Helius Medical Technologies investors own include HubSpot (HUBS), Mazor Robotics (MZOR), Netflix (NFLX), Riot Platforms (RIOT), Tesla (TSLA), Acasti Pharma (ACST) and

Company Calendar

Last Earnings
8/14/2025
Today
10/06/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:HSDT
CIK
1610853
Fax
N/A
Employees
30
Year Founded
2018

Profitability

EPS (Trailing Twelve Months)
($1,976.28)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.74 million
Net Margins
-7,215.25%
Pretax Margin
-7,215.25%
Return on Equity
-699.93%
Return on Assets
-415.24%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.32
Quick Ratio
3.69

Sales & Book Value

Annual Sales
$520 thousand
Price / Sales
35.63
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$212.95 per share
Price / Book
0.08

Miscellaneous

Outstanding Shares
1,080,000
Free Float
884,000
Market Cap
$18.53 million
Optionable
Not Optionable
Beta
1.00

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:HSDT) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners